Talis Biomedical CorpNASDAQ:TLISNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.4900
- TODAY'S CHANGE (%)0.0289 (6.2676%)
- Bid / Lots0.4712/ 13
- Ask / Lots0.5400/ 17
- Open / Previous Close0.5000 / 0.4611
- Day Range
- 52 Week Range
- Volume105,173
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TLIS |
|---|---|---|
| 09:32 ET | 3050 | 0.5 |
| 09:38 ET | 500 | 0.497295 |
| 09:39 ET | 140 | 0.4813 |
| 10:30 ET | 2000 | 0.4841 |
| 10:50 ET | 31796 | 0.4854 |
| 10:51 ET | 200 | 0.48 |
| 10:55 ET | 100 | 0.48 |
| 11:13 ET | 200 | 0.4672 |
| 11:15 ET | 150 | 0.4735 |
| 11:31 ET | 200 | 0.4672 |
| 11:54 ET | 200 | 0.4683 |
| 12:14 ET | 200 | 0.4701 |
| 12:16 ET | 5883 | 0.47505 |
| 12:18 ET | 4880 | 0.47 |
| 12:23 ET | 104 | 0.4701 |
| 12:43 ET | 100 | 0.4721 |
| 12:45 ET | 100 | 0.4721 |
| 12:56 ET | 200 | 0.4721 |
| 01:39 ET | 400 | 0.48 |
| 01:44 ET | 200 | 0.48 |
| 01:46 ET | 100 | 0.48 |
| 01:48 ET | 200 | 0.48 |
| 01:50 ET | 100 | 0.48 |
| 01:51 ET | 100 | 0.48 |
| 01:53 ET | 200 | 0.48 |
| 01:55 ET | 100 | 0.48 |
| 01:57 ET | 100 | 0.48 |
| 02:00 ET | 200 | 0.48 |
| 02:02 ET | 100 | 0.48 |
| 02:04 ET | 200 | 0.48 |
| 02:06 ET | 100 | 0.48 |
| 02:08 ET | 100 | 0.48 |
| 02:09 ET | 200 | 0.48 |
| 02:11 ET | 100 | 0.48 |
| 02:13 ET | 200 | 0.48 |
| 02:15 ET | 100 | 0.48 |
| 02:18 ET | 100 | 0.48 |
| 02:20 ET | 200 | 0.48 |
| 02:22 ET | 100 | 0.48 |
| 02:24 ET | 700 | 0.48 |
| 02:26 ET | 100 | 0.48 |
| 02:27 ET | 100 | 0.48 |
| 02:29 ET | 200 | 0.48 |
| 02:31 ET | 100 | 0.48 |
| 02:33 ET | 2200 | 0.48 |
| 02:36 ET | 4268 | 0.48 |
| 02:38 ET | 14651 | 0.48 |
| 02:40 ET | 200 | 0.49 |
| 02:42 ET | 100 | 0.49 |
| 02:44 ET | 200 | 0.49 |
| 02:45 ET | 100 | 0.49 |
| 02:47 ET | 100 | 0.49 |
| 02:49 ET | 200 | 0.49 |
| 02:51 ET | 100 | 0.49 |
| 02:54 ET | 200 | 0.49 |
| 02:56 ET | 100 | 0.49 |
| 02:58 ET | 200 | 0.49 |
| 03:00 ET | 100 | 0.49 |
| 03:02 ET | 200 | 0.49 |
| 03:03 ET | 100 | 0.49 |
| 03:05 ET | 200 | 0.49 |
| 03:07 ET | 200 | 0.49 |
| 03:09 ET | 1000 | 0.49 |
| 03:12 ET | 200 | 0.49 |
| 03:14 ET | 100 | 0.49 |
| 03:16 ET | 200 | 0.49 |
| 03:18 ET | 200 | 0.49 |
| 03:20 ET | 100 | 0.49 |
| 03:21 ET | 300 | 0.4999 |
| 03:23 ET | 200 | 0.4999 |
| 03:25 ET | 200 | 0.4999 |
| 03:27 ET | 3200 | 0.4999 |
| 03:30 ET | 100 | 0.4999 |
| 03:32 ET | 200 | 0.4999 |
| 03:34 ET | 200 | 0.4999 |
| 03:36 ET | 200 | 0.4999 |
| 03:38 ET | 200 | 0.4999 |
| 03:39 ET | 300 | 0.4999 |
| 03:41 ET | 200 | 0.4999 |
| 03:43 ET | 300 | 0.4999 |
| 03:45 ET | 300 | 0.4999 |
| 03:48 ET | 700 | 0.4999 |
| 03:50 ET | 300 | 0.4999 |
| 03:52 ET | 800 | 0.4999 |
| 03:54 ET | 600 | 0.4999 |
| 03:56 ET | 600 | 0.5 |
| 03:57 ET | 1100 | 0.5 |
| 03:59 ET | 10600 | 0.49 |
May 23, 2023
BRIEF-Talis Biomedical Corp - On May 19 Board Expanded Number Of Directors Of Board From Seven Directors To Eight Directors, from 8:26AM ET on Tuesday May 23, 2023 by Thomson Reuters
8:26AM ET on Tuesday May 23, 2023 by Thomson ReutersTalis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director, from 8:00AM ET on Tuesday May 23, 2023 by GlobeNewswire
8:00AM ET on Tuesday May 23, 2023 by GlobeNewswire
May 11, 2023
BRIEF-Talis Biomedical Announces Business Update And First Quarter 2023 Financial Results, from 4:42PM ET on Thursday May 11, 2023 by Thomson Reuters
4:42PM ET on Thursday May 11, 2023 by Thomson ReutersTalis Biomedical Announces Business Update and First Quarter 2023 Financial Results, from 4:06PM ET on Thursday May 11, 2023 by GlobeNewswire
4:06PM ET on Thursday May 11, 2023 by GlobeNewswire
May 9, 2023
Talis Biomedical Corporation (TLIS) Investor News: Robbins LLP Reminds Investors it is Investigating TLIS on Behalf of Shareholders, from 12:43PM ET on Tuesday May 09, 2023 by GlobeNewswire
12:43PM ET on Tuesday May 09, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Talis Biomedical Corp | 13.2M | -0.1x | --- |
Malachite Innovations Inc | 12.2M | -12.6x | --- |
Aeterna Zentaris Inc | 13.2M | -0.5x | --- |
Ainos Inc | 13.9M | -0.7x | --- |
Pulmatrix Inc | 10.4M | -0.5x | --- |
Aptevo Therapeutics Inc | 11.7M | 0.5x | --- |
Company Information
Talis Biomedical Corporation is engaged in transforming diagnostic testing by developing and commercializing products that are designed to enable molecular testing for infectious diseases and other conditions at the point of care. The Company is engaged in developing the Talis One system, a cloud-enabled molecular diagnostic platform. The Talis One system consists of compact instrument, single-use test cartridges and software that is designed to support a central cloud database, which work together and are designed to provide central laboratory levels of accuracy and be operated by an untrained user. It is also focused on developing Talis One assay kits for respiratory infections, and infections related to women's health and sexually transmitted infections (STIs). It is also developing influenza A and influenza B tests to be included as part of a respiratory panel with its COVID-19 assay (Respiratory Panel), as well as exploring adding a respiratory syncytial virus (RSV) test.
Contact Information
- Headquarters
- 1100 Island Drive, Suite 101REDWOOD CITY, CA, United States 94065
- Phone
- 650-433-3000
- Fax
- 302-636-5454
Executives
- Chief Executive Officer, Director
- Robert Kelley
- Co-Founder, Director
- Rustem Ismagilov
- Chief Financial Officer
- J. Roger Moody
- Lead Independent Director
- Kimberly Popovits
- Director
- Heiner Dreismann
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $13.2M |
|---|---|
Revenue (TTM) | $2.8M |
Shares Outstanding | 26.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.66 |
Book Value | $4.73 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 4.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,558.53% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
